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Liver fibrosis is a dynamic process, which occurs 
due to exposures of various substances or organisms 
that may result in chronic inflammation process in 
the liver. The exposures may include viral infection, 
particularly by hepatitis B virus (HBV), hepatitis C 
virus (HCV) or substances such as alcohol, etc. 
Determining the presence or absence of liver 
fibrosis is a very important issue in order to evaluate 
deterioration phase of advanced inflammation 
process in the liver and to decide when to provide 
appropriate treatment. Liver biopsy is the gold 
standard procedure to identify the severity of fibrosis 
since it has extra advantage, i.e. its ability to   identify 
other abnormalities in the liver in addition to fibrosis 
problem. However, as a main diagnostic procedure, 
liver biopsy is not a perfect major option. Drawbacks 
often mentioned include problems on sampling error, 
inability to demonstrateliver fibrosis globally and 
complication risk at biopsy procedure, which causes 
reluctance to perform biopsy; however, the risk of 
complication rarely occurs in experienced hand. 
Further developments demonstrate that various 
techniques of detecting liver fibrosis through non-
invasive methods have emerged, i.e. by performing 
examination of transient elastography, by using various 
scoring system such as aspartate aminotransferase to 
platelet ratio index (APRI), Hepascore, Fib-4 and blood 
test using FibroTest, which actually aim to detect the 
presence or absence of significant liver fibrosis with 
high accuracy level. 
By using such techniques, the determination of liver 
fibrosis severity does not have to be performed using liver 
biopsy and it can be used by general physician; however, 
the techniques are still not able to determine when 
treatment of chronic hepatitis B and C should be given. 
This issue contains a study conducted by Tarigan et al, 
about utilization of parameters for detecting non-invasive 
fibrosis in the form of a scoring system, which is called 
as the S-index. The index has enriched the numerous 
available scoring systems, which are the blood-based 
markers, with at least of 12 non-invasive methods for 
detecting liver fibrosis based on the examinations of 
blood marker.1 Previous study on the S-index conducted 
by Zhou et al in 386 patients who were hepatitis B carrier 
and compared to liver biopsy demonstrated a high level 
of accuracy, sensitivity and specificity over 80% to detect 
significant liver fibrosis and the index is superior than the 
other six scoring systems.2 
A study of S-index conducted by Tarigan et al 
had smaller sample size (40 patients) than the study 
conducted by Zhou et al and used FibroScan as the 
control, which is not the gold standard of procedure 
in the context of research, which usually make a 
comparison to liver biopsy.2 
When previous studies were taken into consideration, 
FibroScan was also only able to detect moderate and 
advanced liver fibrosis.3 Body mass index, which has 
frequently become the confounding factor of FibroScan, 
was also not mentioned in this study. However, the study 
results show a high level of accuracy for S-index in the 
case of hepatitis B infection and chronic hepatitis C, 
which was made into one sample. 
Those preliminary studies should be appreciated 
for guiding further measures in order to discover the 
standard method on detecting liver fibrosis in Indonesian 
population and therefore, further studies with large 
sample size are necessary and improvements of should 
be made on drawbacks of the available studies. 
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